Matinas BioPharma Holdings Inc (MTNB)

0.59 -0.12 (-16.90%) USD  |  NYAM  |  Nov 14, 10:55
More

Matinas BioPharma Holdings PE Ratio (Forward)

PE Ratio (Forward) Chart

View PE Ratio (Forward) for MTNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical PE Ratio (Forward) Data

View and export this data back to . Upgrade now.
Date Value
November 14, 2024 --

Forward PE Ratio Definition

The Forward Price to Earnings (PE) Ratio is similar to the price to earnings ratio. The regular P/E ratio is a current stock price over its earnings per share. The forward P/E ratio is a current stock's price over its "predicted" earnings per share. If the forward P/E ratio is higher than the current P/E ratio, it indicates decreased expected earnings.

Read full definition.

PE Ratio (Forward) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio (Forward) Benchmarks

Equillium Inc --
Tenon Medical Inc --
Alphatec Holdings Inc --
Merck & Co Inc Upgrade
Madrigal Pharmaceuticals Inc --